Get the Stockscreener App
8.39
3.01%
-0.26
Alpha Cognition Inc stock is traded at $8.39, with a volume of 170.67K.
It is down -3.01% in the last 24 hours and down -4.66% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$8.65
Open:
$8.64
24h Volume:
170.67K
Relative Volume:
2.07
Market Cap:
$182.72M
Revenue:
$10.83M
Net Income/Loss:
$-25.14M
P/E Ratio:
-6.1134
EPS:
-1.3724
Net Cash Flow:
$-30.41M
1W Performance:
-7.19%
1M Performance:
-4.66%
6M Performance:
+24.30%
1Y Performance:
+16.04%
1-Day Range:
$8.15
$8.75
1-Week Range:
$8.55
$9.18
52-Week Range:
$4.50
$10.14
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
8.39 | 182.72M | 10.83M | -25.14M | -30.41M | -1.3724 |
VRTX
Vertex Pharmaceuticals Inc
|
508.43 | 128.87B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.56 | 94.84B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
800.54 | 82.42B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.87 | 53.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.60 | 42.04B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-26 | Initiated | B. Riley Securities | Buy |
| Jul-10-26 | Initiated | Raymond James | Outperform |
| May-29-26 | Initiated | Maxim Group | Buy |
| Apr-17-26 | Initiated | Craig Hallum | Buy |
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition Inc. Common Stock (ACOG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
A 19,050-share purchase leaves Opaleye holding 3,222,954 Alpha Cognition (ACOG) shares. - Stock Titan
Form 4 Alpha Cognition Inc. For: 28 September By Investing.com - Investing.com South Africa
Form 4 Alpha Cognition Inc. For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Alpha Cognition Inc. For: 28 September By Investing.com - Investing.com Canada
Two days of buying: Alpha Cognition (ACOG) 10% owner's fund pays $8.47 and $8.5664 a share. - Stock Titan
Alpha Cognition (ACOG) 10% holder adds 123,918 shares near $8.40–$8.72 - Stock Titan
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 9, 2026 - BioSpace
Alpha Cognition grants new employee 25,000 inducement stock options at USD 9.52 strike price - Bitget
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com
Alpha Cognition grants new employee 25,000 inducement stock options at USD 9.52 strike price - Bitget
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Eastern Progress
Alpha Cognition (ACOG) Up 2.39% to $9.43: Biotech Climbs Toward $9.90 ResistanceSector Neutral Pair - siam.in
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 1, 2026 - BioSpace
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Alpha Cognition (ACOG) director adds 10,000 shares - Stock Titan
Alpha Cognition Inc. Revenue Breakdown – NASDAQ:ACOG - TradingView
Alpha Cognition (NASDAQ:ACOG) Raised to "Strong-Buy" at B. Riley Financial - MarketBeat
Alpha (ACOG) Earnings Update: The Available Figures Are Largely in Line on the Day; Trading Response - vinanet.vn
Alpha Cognition stock wins Buy at B. Riley (ACOG:NASDAQ) - Seeking Alpha
B. Riley Initiates Alpha Cognition at Buy With $21 Price Target - marketscreener.com
B.Riley initiates Alpha Cognition stock with buy, $21 price target - Investing.com India
B.Riley initiates Alpha Cognition stock with buy, $21 price target - Investing.com
Alpha Cognition Inc. (NASDAQ:ACOG) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Alpha (ACOG) Q2 2026 Results: Available Metrics Are Broadly in Line; After Results: The Stock Gains 3.67%Pre-Earnings Drift - vinanet.vn
Alpha (ACOG) Results Review: The Available Figures Are Largely in Line; Market Response: The Share Price Adds 6.12% for the Current SessionRevenue Guidance Range - vinanet.vn
Q3 EPS Estimates for Alpha Cognition Decreased by Analyst - MarketBeat
H.C. Wainwright Maintains Alpha Cognition(ACOG.US) With Buy Rating, Maintains Target Price $20 - Moomoo
H.C. Wainwright raises Alpha Cognition stock price target to $20 By Investing.com - Investing.com South Africa
H.C. Wainwright raises Alpha Cognition stock price target to $20 By Investing.com - Investing.com Nigeria
Q4 EPS Estimates for Alpha Cognition Increased by Analyst - MarketBeat
H.C. Wainwright raises Alpha Cognition stock price target to $20 By Investing.com - Investing.com Canada
H.C. Wainwright raises Alpha Cognition stock price target to $20 - Investing.com
Analysts Conflicted on These Healthcare Names: Alpha Cognition Inc (ACOG) and TScan Therapeutics (TCRX) - The Globe and Mail
Alpha Cognition's Q2 revenue jumps 259%, prompting a 127% price target hike to $20. - Pluang
ACOG Q2 2026 Earnings: Clinical-Stage Net Loss of $0.40 Per Share Slightly Misses ConsensusGuidance Upgrade Report - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
ACOG Maintained by HC Wainwright & Co. -- Price Target Raised to $20.00 - GuruFocus
HC Wainwright Forecasts Strong Price Appreciation for Alpha Cognition (NASDAQ:ACOG) Stock - MarketBeat
Alpha Cognition price target raised to $20 from $18 at H.C. Wainwright - TipRanks
Alpha Cognition's Q2 revenue jumps 71% as ZUNVE... - Pluang
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26 - Yahoo Finance
Alpha Cognition (ACOG) Stock Fair Value Rises After Zunveyl Analyst Optimism - Yahoo Finance
Alpha Cognition (ACOG) Gains 2.43% to $8.84, Approaching Key Resistance at $9.28Value Factor - vinanet.vn
Alpha Cognition (ACOG) Gains 2.43% to $8.84, Approaching Key Resistance at $9.28High Reward Trades - dars.gov.et
Alpha Cognition (ACOG) Gains 2.43% to $8.84, Approaching Key Resistance at $9.28Momentum Stock Picks - dars.gov.et
Alpha Cognition reports Q2 EPS (40c), consensus (39c) - TipRanks
Alpha Cognition price target raised to $17 from $14 at Craig-Hallum - TipRanks
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alpha Cognition Inc Stock (ACOG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Sep 25 '26 |
Buy |
8.47 |
13,426 |
113,718 |
3,203,904 |
| Opaleye Management Inc. | 10% Owner |
Sep 24 '26 |
Buy |
8.57 |
18,337 |
157,082 |
3,190,478 |
| Opaleye Management Inc. | 10% Owner |
Sep 16 '26 |
Buy |
8.51 |
80,170 |
682,591 |
3,172,141 |
| Opaleye Management Inc. | 10% Owner |
Sep 15 '26 |
Buy |
8.54 |
3,375 |
28,831 |
3,091,971 |
| Opaleye Management Inc. | 10% Owner |
Sep 14 '26 |
Buy |
8.70 |
40,373 |
351,084 |
3,088,596 |
| Wills Robert James | Director |
Aug 21 '26 |
Buy |
9.62 |
10,000 |
96,200 |
32,241 |
| Opaleye Management Inc. | 10% Owner |
Aug 03 '26 |
Buy |
8.00 |
50,000 |
400,000 |
3,048,223 |
| Opaleye Management Inc. | 10% Owner |
Jul 31 '26 |
Buy |
7.92 |
2,900 |
22,976 |
2,998,223 |
| Opaleye Management Inc. | 10% Owner |
Jul 24 '26 |
Buy |
7.90 |
130 |
1,027 |
2,995,323 |
| Opaleye Management Inc. | 10% Owner |
Jul 23 '26 |
Buy |
7.80 |
49,849 |
388,588 |
2,995,193 |
3.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):